Search results
US CDC recommends updated COVID vaccines for those aged six months and older
Reuters via Yahoo News Singapore· 3 days agoThe agency's recommendation on Thursday echoed that of its panel of outside experts, who voted...
GSK shares slide after US health agency narrows scope of RSV shots
Reuters via Yahoo Singapore Finance· 4 days agoBritain's GSK launched RSV vaccine Arexvy in the United States last summer after it and a rival shot...
Why Is Moderna Stock Trading Lower On Wednesday?
Benzinga via Yahoo Singapore Finance· 4 days agoThe Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practice will meet this week to consider and recommend who should get...
Novavax (NVAX) Seeks Nod for Updated COVID-19 Jab in Europe
Zacks via Yahoo Singapore Finance· 5 days agoNovavax (NVAX) seeks marketing authorization in the European Union for an updated version of its...
EU prosecutors probe former EIB chief for corruption, misappropriation
Euronews via Yahoo News Singapore· 6 days agoThe EPPO was launched in 2021 to investigate issues such as farm subsidy fraud, but has also taken...
CDC Advisor Panel Recommends RSV Shots In US For People Above 75 Years, Analyst Says Decision...
Benzinga via Yahoo Singapore Finance· 3 days agoOn Wednesday, the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on...
The Top Country With Most Scientists per Capita in the World
Insider Monkey via Yahoo Singapore Finance· 24 hours agoWe recently compiled a list of the 10 Countries With the Most Scientists per Capita in the World and...
Older people and pregnant women to be offered new NHS respiratory virus jab
PA Media: UK News via Yahoo News Singapore· 5 days agoFrom September, anyone aged 75 and over (as of September 1) will be offered one dose of Pfizer’s jab...
Merck's (MRK) Lung Cancer Candidate Faces FDA Rejection
Zacks via Yahoo Singapore Finance· 3 days agoThe FDA's CRL to Merck (MRK) and its partner Daiichi Sankyo for the patritumab deruxtecan BLA is...
Moderna shares decline, RSV vaccine efficacy lags behind competitors
Investing.com via Yahoo Singapore Finance· 4 days agoInvesting.com - Moderna Inc (NASDAQ:MRNA) experienced an 11% drop on Wednesday after the company disclosed that its respiratory syncytial virus (RSV) vaccine, mResvia, exhibited 50% efficacy in preventing the illness 18 months post-administration.
